In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Sorin Group: Europe's Last, Best Hope in Cardiovascular Devices

Executive Summary

The contribution that Europeans, particularly European physicians and surgeons, have made to the cardiology and cardiovascular industries has been enormous. Why then have Europeans lagged far behind their US counterparts in one important area--company creation? If there is a candidate to play in the cardiovascular device industry's elite ranks, it's Sorin Group, a company with a diverse holding in a wide range of cardiology and cardiovascular device segments.

You may also be interested in...



Sorin Restructured: Interview with Andre-Michel Ballester

Sorin, as a whole, has historically been known as a company more focused on R&D and technology development than on the commercial side of the business. Despite being among the market leaders in several cardiovascular product segments in both Europe and Asia, outside of cardiopulmonary devices Sorin is not a significant player in any other US product area. Sorin's CEO talks frankly to IN VIVO about why the company needed to reorganize to bring its sales and marketing efforts, particularly in the US, up to the level of its technology development.

Sorin Restructured: Interview with Andre-Michel Ballester

Sorin, as a whole, has historically been known as a company more focused on R&D and technology development than on the commercial side of the business. Despite being among the market leaders in several cardiovascular product segments in both Europe and Asia, outside of cardiopulmonary devices Sorin is not a significant player in any other US product area. Sorin's CEO talks frankly to IN VIVO about why the company needed to reorganize to bring its sales and marketing efforts, particularly in the US, up to the level of its technology development.

Sorin CRM: Cracking the US Market

Sorin's history of important technology breakthroughs has long been one of the best kept secrets in the cardiac rhythm management market. The company is now restructuring to focus on CRM, particularly in the US, and challenge the major players on their home turf.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

IV002416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel